Announcements Trials

Browse Landscape

Phase

Status

Recruiting 23 Active not recruiting 13 Not yet recruiting 8 Terminated 7 Unknown 3 Completed 3 Withdrawn 1 Suspended 1 Approved for marketing 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Sarcoma 1 Head & Neck 1 Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 4 Docetaxel 3 pembrolizumab 2 Nivolumab 2 Etoposide 2 Carboplatin 2 osimertinib 1 icotinib 1 famitinib 1 durvalumab 1 decitabine and cedazuridine drug combination 1 dabrafenib 1 cemiplimab 1 alirocumab 1 aldesleukin 1 Surgical Procedures, Operative 1 Specimen Handling 1 Radiotherapy 1 Radiosurgery 1 Radionuclide Imaging 1 Radiation 1 Prednisone 1 Positron-Emission Tomography 1 Platinum 1 Pemetrexed 1 Panitumumab 1 Paclitaxel 1 Monatide (IMS 3015) 1 Methods 1 Magnetic Resonance Spectroscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Suspended × cemiplimab × Thoracic × Clear all

NCT06385262 2026-03-06

TOP 2301: Neoadjuvant Chemo for NSCLC

Duke University

Phase 2 Suspended

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡